E1A 12S IN THE ABSENCE OF E1B OR OTHER COOPERATING ONCOGENES ENABLES CELLS TO OVERCOME APOPTOSIS

被引:0
|
作者
QUINLAN, MP
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neonatal rat kidneys are still undergoing growth and differentiation. Within 24 h after placing these cells in culture, programmed cell death has been activated. This is evidence by intranucleosomal DNA digestion. Cellular DNA synthesis and proliferation cease between 48 and 72 h after plating and the epithelial cells begin to die. The adenovirus E1A 12S gene, in the presence or absence of the E1B gene products, restarts the proliferation program of these cells, retaining their differentiated states. 12S can accomplish this in the presence and absence of serum. Expression of the E1A 13S gene results in cellular DNA degradation due to necrosis, but not apoptosis, brought on by the expression of the 13S-dependent viral genes. Those cells that retain the 12S sequences escape apoptosis and proceed to become immortal. In addition, 12S enables Madin Darby canine kidney (MDCK) epithelial cells to overcome TGF-beta 1 induced inhibition of proliferation and apoptosis. Thus, E1A 12S may be an anti-apoptotic gene.
引用
收藏
页码:3289 / 3296
页数:8
相关论文
共 50 条
  • [21] E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP
    Trouche, D
    Kouzarides, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1439 - 1442
  • [22] Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b
    F Hedjran
    K Shantanu
    R Tony
    Cancer Gene Therapy, 2011, 18 : 717 - 723
  • [23] THE ADENOVIRUS E1A PROTEINS INDUCE APOPTOSIS, WHICH IS INHIBITED BY THE E1B 19-KDA AND BCL-2 PROTEINS
    RAO, L
    DEBBAS, M
    SABBATINI, P
    HOCKENBERY, D
    KORSMEYER, S
    WHITE, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7742 - 7746
  • [24] E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer
    Fukuda, K
    Abei, M
    Ugai, H
    Seo, E
    Wakayama, M
    Murata, T
    Todoroki, T
    Tanaka, N
    Hamada, H
    Yokoyama, KK
    CANCER RESEARCH, 2003, 63 (15) : 4434 - 4440
  • [25] Esophagogastric adenocarcinoma in an E1A/E1B transgenic model involves p53 disruption
    Mark D. Duncan
    Tarik Tihan
    David M. Donovan
    Quy H. Phung
    Dan L. Rowley
    John W. Hamon
    Patricia J. Gearhart
    Kimberly L. K. Duncan
    Journal of Gastrointestinal Surgery, 2000, 4 : 290 - 297
  • [26] Esophagogastric adenocarcinoma in an E1A/E1B transgenic model involves p53 disruption
    Duncan, MD
    Tihan, T
    Donovan, DM
    Phung, QH
    Rowley, DL
    Harmon, JW
    Gearhart, PJ
    Duncan, KLK
    JOURNAL OF GASTROINTESTINAL SURGERY, 2000, 4 (03) : 290 - 297
  • [27] EXPRESSION OF ADENOVIRUS E1A AND E1B GENE-PRODUCTS AND THE ESCHERICHIA-COLI XGPRT GENE IN KB CELLS
    BABISS, LE
    YOUNG, CSH
    FISHER, PB
    GINSBERG, HS
    JOURNAL OF VIROLOGY, 1983, 46 (02) : 454 - 465
  • [28] Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells
    Wei, Fang
    Wang, Huiping
    Chen, Xiafang
    Li, Chuanyuan
    Huang, Qian
    CANCER BIOLOGY & THERAPY, 2014, 15 (10) : 1358 - 1366
  • [29] INDUCTION OF INTEGRATED ADENOVIRUS E1A AND E1B GENES IN TRANSFORMED HUMAN-CELLS BY PHORBOL ESTER TUMOR PROMOTERS
    CARTER, T
    JAMES, C
    CHAN, E
    GREENE, B
    CANCER RESEARCH, 1987, 47 (03) : 803 - 808
  • [30] Erratum: Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b
    F Hedjran
    K Shantanu
    R Tony
    Cancer Gene Therapy, 2011, 18 (10) : 760 - 760